Technology Development

Translating Scientific Discoveries Into Medical Practice 

		Technology Development
		Success Stories Collaboration Opportunities Licensing Opportunities Join the NIH Office of Technology Transfer Listserv for updates on licensing and collaboration opportunities

NIAID has been at the forefront of cutting-edge biomedical research for decades. The work performed in its labs has furthered the understanding of the immune system and led to significant advances in the fields of immunology and infectious disease research.

But it’s a long path from basic scientific discoveries to approved vaccines, treatments, or diagnostic tools. NIAID is constantly pursuing collaborations with industry and academia to develop its technologies and materials into products that improve public health.

The NIAID Office of Technology Development (OTD) facilitates collaborative relationships between NIAID investigators and the broader scientific community.  

Highlighted Licensing and Collaboration Opportunities

• Chikungunya vaccine: Virus-like proteins (VLPs) have shown to be more effective than DNA vaccines in a mouse model
• Poultry influenza vaccine: Elicits antibodies proven effective in preclinical testing
• HIV vaccine: Epitope-transplant scaffolds may help to identify antigens against HIV-1 surface proteins
• MAOIs could prevent herpesvirus infections and, possibly, reactivation from latency

Recent Happenings

See Technology Development Recent Happenings.

back to top